Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,987 | 16,604 | 20,728 | 17,603 | 26,245 |
| Receivables | 9,036 | 12,674 | 7,451 | 7,639 | 8,603 |
| Other current assets | 4,495 | 4,123 | 4,266 | 4,380 | 4,636 |
| TOTAL | $32,518 | $33,401 | $32,445 | $29,622 | $39,484 |
| Non-Current Assets | |||||
| PPE Net | 24,817 | 25,462 | 26,135 | 26,966 | 27,828 |
| Intangibles | 18,914 | 19,406 | 19,902 | 20,391 | 20,905 |
| Other Non-Current Assets | 11,227 | 10,453 | 9,258 | 9,262 | 9,027 |
| TOTAL | $54,958 | $55,321 | $55,295 | $56,619 | $57,760 |
| Total Assets | $87,476 | $88,722 | $87,740 | $86,241 | $97,244 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6 | 11 | 16 | 18 | 21 |
| Accounts payable and accrued liabilities | 3,080 | 3,617 | 2,973 | 2,925 | 2,194 |
| Accrued Expenses | 11,033 | 9,720 | 9,684 | 7,403 | 10,064 |
| Other current liabilities | 992 | 637 | 638 | 1,088 | 641 |
| TOTAL | $17,436 | $18,152 | $15,160 | $13,316 | $14,317 |
| Non-Current Liabilities | |||||
| Long Term Debt | 47,445 | 47,111 | 46,782 | 36,693 | 36,408 |
| Deferred Revenues | 961 | 2,773 | 617 | 788 | 678 |
| Other Non-Current Liabilities | 25,060 | 25,181 | 24,660 | 25,172 | 25,643 |
| TOTAL | $72,505 | $72,292 | $71,442 | $61,865 | $62,051 |
| Total Liabilities | $89,941 | $90,444 | $86,602 | $75,181 | $76,368 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,858 | 7,956 | 7,332 | 7,328 | 7,299 |
| Common Shares | 8 | 8 | 146 | 146 | 7 |
| Retained earnings | -497,762 | -493,782 | -485,066 | -473,598 | -462,497 |
| TOTAL | $-2,465 | $-1,722 | $1,138 | $11,060 | $20,876 |
| Total Liabilities And Equity | $87,476 | $88,722 | $87,740 | $86,241 | $97,244 |